Now Offering Spravato Treatments

Spravato® (esketamine intranasal) is a prescription, FDA-approved nasal spray made up of the chemical esketamine, which is made from ketamine, an anesthetic drug that is also used to treat depression at subanesthetic doses. It is administered in a healthcare clinic.

Spravato is the only nasal spray formulation of ketamine on the market. The dose of Spravato and subanesthetic ketamine may vary. One is not necessarily better than the other. Both have a value and utility in the treatment of psychiatric illnesses.

Spravato treatment varies based on an individual’s specific needs, but generally, the treatment includes giving yourself 3 doses of the nasal spray, spaced about 5 minutes apart, under medical supervision in a medical clinic.

Each treatment session lasts approximately two hours, during which patients are monitored in a comfortable, safe, and secure setting. Due to the possible side effects of the treatment, you are not permitted to drive yourself home afterwards; you must be picked up by a friend, family member, or ride share service..

Spravato is for adults with treatment-resistant depression (TRD) and major depressive disorder (MDD)

Spravato is not approved for use by children. You should not use Spravato if you are pregnant or plan to become pregnant, have a history of substance abuse, including alcoholism, blood vessel disease or a history of bleeding in the brain, uncontrolled hypertension, or other medical contraindications.